Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins DownZacks Investment Research • 02/27/26
Solventum (SOLV) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/26/26
Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year GuidancePRNewsWire • 02/26/26
Curious about Solventum (SOLV) Q4 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 02/23/26
Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026PRNewsWire • 02/03/26
Are Medical Stocks Lagging Solventum Corporation (SOLV) This Year?Zacks Investment Research • 12/30/25
SOLV Acquires Acera Surgical to Expand Advanced Wound Care PortfolioZacks Investment Research • 12/24/25
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure TherapyPRNewsWire • 12/17/25
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain StrengthPRNewsWire • 12/16/25
These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them?The Motley Fool • 12/05/25
Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference TranscriptSeeking Alpha • 12/02/25
Solventum Corporation (SOLV) Presents at Stifel 2025 Healthcare Conference TranscriptSeeking Alpha • 11/12/25